Mannatech MTEX Q3 2023 Earnings Narrow Profit as Revenue Challenges Persist EXAS Q4 2025 Earnings Significant EPS Miss Raises Questions on Path to Profitability USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues The Travelers Companies TRV Q1 2026 Earnings EPS Beats Estimates Amid Solid Underwriting Performance MSCI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Steady Performance